2-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol

Catalog No. :
ACBIZN076
CAS No. :
2121514-31-4
Molecular Formula :
C13H19BO4
Molecular Weight :
250.10

IUPAC Name:2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol

2-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$227.00Login to see priceInquiryInquiry
250mg97%$364.00Login to see priceIn stockInquiry
1g97%$949.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
IUPAC Name2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
Molecular FormulaC13H19BO4
Molecular Weight250.10
SMILESCOC1=C(O)C=CC=C1B2OC(C)(C)C(C)(C)O2
InChI KeyAQXQPYZUYHUEAU-UHFFFAOYSA-N
Synonym3-Hydroxy-2-methoxybenzeneboronic acid, pinacol ester;Phenol, 2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;2-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
CAS No.2121514-31-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBIZN076 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACJOME572 route compound structure diagram
    ACJOME57288275-88-1 In Stock
  4. Then
  5. ACBIZN076 route product structure diagram
    ACBIZN0762121514-31-4 In Stock
Inquiry

2. ACBIZN076 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBIZN076 route product structure diagram
    ACBIZN0762121514-31-4 In Stock
Inquiry

Comments (0)